🔎 Trials Near Me

Home › Myelofibrosis › Tennessee › Nashville

Myelofibrosis clinical trials in Nashville, TN

9 studies for Myelofibrosis are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

RecruitingPhase 1/2
  • Tri-Star Centennial Medical Center, Nashville
  • Vanderbilt University, Nashville
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT04176198

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

RecruitingPhase 1
  • Tennessee Oncology, PLLC - Investigational Drug Services, Nashville
  • Tristar BMT, Nashville
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07469891

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

RecruitingPhase 3
  • Vanderbilt-Ingram Cancer Center (VICC)-Nashville, Nashville
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07623161

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

RecruitingPhase 2
  • Vanderbilt University/Ingram Cancer Center, Nashville
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT06661915

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

RecruitingPhase 1
  • Tristar Bmt/Tcto, Nashville
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT07441694

Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

RecruitingPhase 2
  • GSK Investigational Site, Nashville
Ages 18 and older · All sexes · Updated Apr 20, 2026 · NCT06517875

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

RecruitingPhase 1
  • Vanderbilt University Medical Center, Nashville
Ages 18 and older · All sexes · Updated Apr 17, 2026 · NCT06034002

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Nashville
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

RecruitingPhase 3
  • Tennessee Oncology, Nashville
  • Vanderbilt University Medical Center, Nashville
Ages 18 and older · All sexes · Updated Sep 25, 2025 · NCT06479135

Myelofibrosis trials in other cities

Other studies in Nashville

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.